Ksimelin Nazal drop. 0.1% 10ml-vial cap.

$1.82

Ksimelin Nazal drop. 0.1% 10ml-vial cap.

Quantity:

SKU: 1105832056 Categories: , , Tags: ,

Description

Composition
Active substance:
1 ml contains: Xylometazoline hydrochloride 0.5 mg or 1 mg.
Excipients:
Edetat- Disodium 0.5 mg / 0.5 mg sodium hydrogen phosphate dihydrate 2 mg / 2 mg sodium dihydrogen phosphate dihydrate 2 mg / 2 mg sodium chloride 7.4 mg / 7.3 mg, benzalkonium chloride 0 , 1 mg / 0.1 mg, purified water, 991.5 mg / 991.1 mg.
Description:
Transparent colorless liquid.
Product form:
Nasal drops 0.05% and 0.1%. 10 ml vial formulation IV-low density polyethylene. The vial was sealed screw cap of polypropylene. 1 bottle together with instructions for use placed in a cardboard box.
Contraindications
Increased sensitivity to the drug, hypertension, tachycardia, expressed atherosclerosis, glaucoma, atrophic rhinitis, hyperthyroidism, surgical interventions in the meninges (history), the state after transsphenoidal hypophysectomy, pregnancy, children up to 2 years (ksimelin 0.05% ); children up to six years (ksimelin 0.1%). Do not use the drug in the therapy of inhibitors of monoamine oxidase (MAO) or tricyclic antidepressants, including the period of 14 days after their withdrawal.
Carefully
Diabetes, diseases of the cardiovascular system, including Coronary artery disease, angina, porphyria, lactation, prostatic hyperplasia, and increased sensitivity to adrenergic agents, accompanied by insomnia, dizziness, arrhythmia, tremor, increased blood pressure.
Dosage
1 mg / ml
Indications
Acute respiratory illness with symptoms of rhinitis (common cold), acute allergic rhinitis, hay fever, sinusitis, evstahiit, otitis media (to reduce nasopharyngeal mucosa edema). Preparing the patient for diagnostic procedures in the nasal passages.
Interaction with other drugs
Application Xylometazoline contraindicated in patients receiving tricyclic antidepressants, MAO or to the period after their withdrawal. The simultaneous use of tri- or tetracyclic antidepressants and sympathomimetic drugs can lead to increased sympathomimetic effect of xylometazoline, however such combinations should be avoided.
Overdose
Xylometazoline local administration of excessive doses or accidental ingestion can cause severe dizziness, irregular pulse, sweating, a sharp decrease in body temperature, headache, bradycardia, hypertension, respiratory depression, coma and convulsions. Following the increase in blood pressure can be observed its sharp decline. Appropriate supportive measures should be taken in any suspected overdose, in some cases shown immediate symptomatic treatment under the supervision of a physician. These should include monitoring the patient for several hours. In case of severe poisoning with cardiac arrest.
pharmachologic effect
Pharmacological group:
Decongestant agent – alpha-agonists.
Pharmacological properties:
Xylometazoline refers to a group of local vasoconstrictive agents (decongestants) with alpha-adrenomimeticheskim action causes vasoconstriction of nasal mucosa, eliminating mucosal swelling and nasal congestion. Facilitates nasal breathing. At therapeutic concentrations do not irritate the nasal mucosa, does not cause flushing. Effect occurs within 2 minutes after application and lasts for 10 – 12 hours. In vitro studies have shown that ksilometazolin inhibit the infectious activity of the human rhinovirus, which causes “cold.”
Pharmacokinetics:
When applied topically, practically not absorbed, the plasma concentrations are so small that they can not identify with modern analytical methods.
Pregnancy and breast-feeding
Use of the drug is contraindicated in pregnancy. During breastfeeding the drug should only be used after careful assessment of risks and benefits for mother and child, under the supervision of a physician. It is not allowed to exceed the recommended dose.
Conditions of supply of pharmacies
Without recipe.
side effects
The classification of the frequency of occurrence of adverse reactions: very often (> 1/10); common (> 1/100,
special instructions
Should not be used for a long time (more than 10 days), for example, in chronic rhinitis. Long term (over 10 days) or excessive use may cause the effect of “rebound” (rhinitis medicamentosa) and / or atrophy of nasal mucosa. Do not exceed the recommended dose, especially in children and the elderly. If after 10 days symptoms persist, seek medical advice
The effect on the ability to operate a vehicle or equipment
The drug at the recommended doses does not affect the ability to drive a vehicle or equipment that require high concentration and psychomotor speed reactions.
Storage conditions
At a temperature of not higher than 25 C.
Keep out of the reach of children.
Dosing and Administration
Intranasally. 0.05% drop for children from 2 to 6 years: 1-2 drops in each nostril 1-2 times a day; should not be used more than 3 times a day. 0.1% drop for adults and children over 6 years: 2-3 drops in each nostril (can be repeated if necessary); should not be used more than 3 times a day.
The drug is administered not more than 10 days.
The drug in children should be used under adult supervision only.
Use according to the drug only indications that the application and in those doses which are specified in the instruction.
Use according to the drug only indications that the application and in those doses which are specified in the instruction.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

TAKEDA

There are no reviews yet.

Add your review